GLP-1 use cuts risk for atrial fibrillation regardless of weight loss

Summary: Have you heard about drugs like Ozempic and Wegovy? While they are famous for helping people lose weight, doctors have discovered a secret superpower: they protect your heart, even if you don't lose a single pound.

A new study shows that people taking GLP-1 medications have a much lower risk of developing a dangerous irregular heartbeat called atrial fibrillation (AFib). The amazing part is that the bathroom scale doesn't matter. Whether patients lost a lot of weight, a little, or even gained weight, their hearts were still protected. Doctors believe these medicines work by calming down angry inflammation, especially in the hidden fat wrapped around the heart. This means these drugs are doing much more than changing how we look—they are actually changing how our hearts beat from the inside out.

For more details, see rssapp-healio-com-cardiology at healio.com/news/cardiology/20260423/glp1-use-cuts-risk-for-atrial-fibrillation-regardless-of-weight-loss (opens in new tab)